Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Mohammed Milhem, MBBS discussed the mechanism of action of RP1, the design and preliminary findings of the IGNYTE trial in ...

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in poster format at the American Association ...

Q1 2025 Management View CEO Pascal Soriot emphasized that AstraZeneca's total revenue grew by 10% in Q1 2025, with core operating profit increasing by 12% and core EPS by 21%. Growth was supported by ...

This came after the firm presented their proposal for the manufacturing and marketing of Roflumilast Cream 0.3% w/w for the ...

RO7589831, a new drug from Roche, is first in a new class of drugs called Werner helicase inhibitors. Drug works similarly to ...

Biologics may have a more favorable profile, whereas JAK inhibitors (JAKi) may be more risky due to their ... medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no.

inhibitor use in cats, specific to Senvelgo (velagliflozin oral solution) and Bexacat (bexagliflozin tablets). She discusses gastrointestinal symptoms, ketosis and diabetic ketoacidosis (DKA), ...

April 16, 2025. Frankfurt, London: Bitwise has listed four of its Germany-issued crypto Exchange Traded Products (ETPs) at the London Stock Exchange (LSE), expanding access to its institutional ...

SGLT2 inhibitors offer significant benefits in CKD and HF, yet remain underutilized in primary care settings. An interprofessional initiative developed a prescription algorithm to enhance SGLT2 ...